"RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A TRIAL OF EFFICACY AND SAFETY OF EVOLOCUMAB FOR PCSK9 LOWERING IN EARLY ACUTE SEPSIS. THE (PLEASE) STUDY."

Registry ID

02-MAR-2018

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ST PAULS HOSPITAL VANCOUVER

Start date

2019-09-11

Last update

2018-08-17

Conditions

• SEPSIS

Related clinical trials

• BETA-BLOCKER THERAPY VERSUS STANDARD CARE IN PATIENTS WITH SEPTIC SHOCK: A PILOT RANDOMIZED CONTROLLED TRIAL UTILIZING PREDICTIVE ENRICHMENT WITH POINT-OF-CARE ULTRASOUND
• INTRAVENOUS DNASE I FOR THE TREATMENT OF SEPSIS: A PHASE I SAFETY AND FEASIBILITY STUDY IN ICU PATIENTS
• PRAGMATIC PEDIATRIC TRIAL OF BALANCED VERSUS NORMAL SALINE FLUIDS IN SEPSIS (PROMPT BOLUS)
• LESSENING ORGAN DYSFUNCTION WITH VITAMIN C ¿ COVID (LOVIT-COVID)
• LESSENING ORGAN DYSFUNCTION WITH VITAMIN C (LOVIT).

View on source registry